Leadless Pacemaker
0
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
2029
BiotronikLivIQ Leadless Pacemaker System
AbbottAveir DR Leadless Pacemaker Implant
Clinical Trials (2)
Total enrollment: 629 patients across 2 trials
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
Start: Mar 2026Est. completion: Apr 2028325 patients
N/ARecruiting
Aveir Leadless Pacemaker Japan PMS
Start: May 2025Est. completion: Nov 2029304 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 629 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.